Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Jeremy Clarkson's partner Lisa shares his heartbreaking words after cancer diagnosis
46+ min ago (567+ words) Thousands of men got checked after they decided to include it on the show Lisa Hogan has shared what Jeremy Clarkson said when he was diagnosed with prostate cancer and a decision was made over whether to include it on…...
Passenger in medical distress airlifted from cruise ship 200 km northwest of Port Hardy
5+ hour, 19+ min ago (150+ words) CTV News Officials say a passenger on board a cruise ship 200 kilometres off the coast of Port Hardy, B.C., was airlifted to Comox for medical care on Saturday An update from the Joint Rescue Coordination Centre Victoria detailed that rescue teams…...
Partner says Jeremy Clarkson going public with cancer diagnosis helped thousands
6+ hour, 57+ min ago (257+ words) Jeremy Clarkson's partner says his decision to go public with his prostate cancer diagnosis has helped thousands of people. The former Top Gear presenter is in remission after revealing on the latest series of Clarkson's Farm that he had been…...
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial
5+ hour, 35+ min ago (12+ words) firstwordpharma.com...
Breast cancer pill from AstraZeneca misses mark in pivotal trial
1+ day, 4+ hour ago (204+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
AstraZeneca’s breast cancer pill fails in late-stage trial
2+ day, 2+ hour ago (301+ words) Sept 11 (Reuters) – AstraZeneca’s breast cancer pill failed to meet the main goal of improving progression-free survival in a late-stage trial, the company said on Friday, a week after the treatment received U.S. approval. U.S.-listed shares of AstraZeneca…...
AstraZeneca’s breast cancer pill fails in a late-stage trial
2+ day, 26+ min ago (281+ words) AstraZeneca’s breast cancer pill failed to meet the main goal of improving progression-free survival in a late-stage trial, the company said on Friday, a week after the treatment received US approval. US-listed shares of AstraZeneca fell 3% in aftermarket trading. The…...
AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus
2+ day, 5+ hour ago (424+ words) Etcamah is a once-daily pill that breaks down the estrogen receptor many breast cancers use to grow and is already approved for a narrower group of breast cancer patients. The setback lands on a pipeline already under scrutiny. Shares of…...
AstraZeneca Trips On Unexpected Failure In Breast Cancer
1+ day, 14+ hour ago (138+ words) AstraZeneca stock toppled in late trades Friday after the company's experimental breast cancer treatment failed to pass muster. The post AstraZeneca Stock Trips On Unexpected Failure In Breast Cancer appeared first on Investor's Business Daily. AstraZeneca (AZN) stock toppled in…...
Astrazeneca’s breast cancer drug fails late-stage trial
1+ day, 14+ hour ago (77+ words) Sept 11 (Reuters) - AstraZeneca said on Friday its breast cancer drug failed to meet the main goal of improving progression-free survival during a late-stage trial. (Reporting by Christy Santhosh in Bengaluru; Editing by Tasim Zah... Astrazeneca’s breast cancer drug fails late-stage…...